IDN 7314

Drug Profile

IDN 7314

Alternative Names: IDN7314

Latest Information Update: 25 Jul 2016

Price : $50

At a glance

  • Originator Conatus Pharmaceuticals
  • Class Amides; Antifibrotics; Fluorobenzenes; Hepatoprotectants; Pentanoic acids; Phenyl ethers; Small molecules
  • Mechanism of Action Apoptosis inhibitors; Caspase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Preclinical Hepatocellular carcinoma

Most Recent Events

  • 13 Apr 2016 Preclinical trials in Hepatocellular carcinoma in USA (PO)
  • 13 Apr 2016 Preclinical data in Hepatocellular carcinoma presented at the The International Liver Congress (ILC-2016)
  • 30 Mar 2016 Early research in Hepatocellular carcinoma in USA (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top